#aaeth ,,congress #b;d ,session ,h4 ,r4 #dbhd ,,an ,,act ,to establish a substance use disorder information dashboard within the ,department of ,health and ,human ,services1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,indexing ,narcotics1 ,fentanyl1 and ,opioids ,act of #bjah or the ,,info ,act4 #b4 ,establishment of substance use disorder information dashboard ,title ,,xvii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjju et seq47 is amended by adding at the end the following new section3 #agaa4 ,establishment of substance use disorder information dashboard 7a7 ,in general ,not later than #f months after the date of the enactment of this section1 the ,secretary of ,health and ,human ,services shall1 in consultation with the ,director of ,national ,drug ,control ,policy1 establish and periodically update a public information dashboard that-- 7#a7 coordinates information on programs within the ,department of ,health and ,human ,services related to the reduction of opioid abuse and other substance use disorders2 7#b7 provides access to publicly available data from other ,federal agencies2 ,state1 local1 and ,tribal governments2 nonprofit organizations2 law enforcement2 medical experts2 public health educators2 and research institutions regarding prevention1 treatment1 recovery1 and other services for opioid use disorder and other substance use disorders2 7#c7 provides comparable data on substance use disorder prevention and treatment strategies in different regions and population of the ,united ,states2 7#d7 provides recommendations for health care providers on alternatives to controlled substances for pain management1 including approaches studied by the ,national ,institutes of ,health ,pain ,consortium and the ,national ,center for ,complimentary and ,integrative ,health2 and 7#e7 provides guidelines and best practices for health care providers regarding treatment of substance use disorders4 7b7 ,controlled substance defined ,in this section1 the term controlled substance has the meaning given that term in section #ajb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb74 4 #c4 ,interagency ,substance ,use ,disorder ,coordinating ,committee 7a7 ,establishment ,not later than #c months after the date of the enactment of this ,act1 the ,secretary of ,health and ,human ,services 7in this section referred to as the ,secretary7 shall1 in consultation with the ,director of ,national ,drug ,control ,policy1 establish a committee1 to be known as the ,interagency ,substance ,use ,disorder ,coordinating ,committee 7in this section referred to as the ,committee71 to coordinate all efforts within the ,department of ,health and ,human ,services concerning substance use disorder4 7b7 ,membership 7#a7 ,federal members ,the following individuals shall be the ,federal members of the ,committee3 7,a7 ,the ,secretary1 who shall service as the ,chair of the ,committee4 7,b7 ,the ,attorney ,general of the ,united ,states4 7,c7 ,the ,secretary of ,labor4 7,d7 ,the ,secretary of ,housing and ,urban ,development4 7,e7 ,the ,secretary of ,education4 7,f7 ,the ,secretary of ,veterans ,affairs4 7,g7 ,the ,commissioner of ,social ,security4 7,h7 ,the ,assistant ,secretary for ,mental ,health and ,substance ,use4 7,i7 ,the ,director of the ,centers for ,disease ,control and ,prevention4 7,j7 ,the ,director of the ,national ,institutes of ,health and the ,directors of such national research institutes of the ,national ,institutes of ,health as the ,secretary determines appropriate4 7,k7 ,the ,administrator of the ,centers for ,medicare ,medicaid ,services4 7,l7 ,the ,director of ,national ,drug ,control ,policy4 7,m7 ,representatives of other ,federal agencies that serve individuals with substance use disorder4 7#b7 ,non-,federal members ,the ,committee shall include a minimum of #ag non-,federal members appointed by the ,secretary1 of which-- 7,a7 at least two such members shall be an individual who has received treatment for a diagnosis of an opioid use disorder2 7,b7 at least two such members shall be an individual who has received treatment for a diagnosis of a substance use disorder other than an opioid use disorder2 7,c7 at least two such members shall be a ,state ,alcohol and ,substance ,abuse ,director2 7,d7 at least two such members shall be a representative of a leading research1 advocacy1 or service organization for adults with substance use disorder2 7,e7 at least two such members shall-- 7i7 be a physician1 licensed mental health professional1 advance practice registered nurse1 or physician assistant2 and 7ii7 have experience in treating individuals with opioid use disorder or other substance use disorders2 7,f7 at least one such member shall be a substance use disorder treatment professional who is employed with an opioid treatment program2 7,g7 at least one such member shall be a substance use disorder treatment professional who has research or clinical experience in working with racial and ethnic minority populations2 7,h7 at least one such member shall be a substance use disorder treatment professional who has research or clinical mental health experience in working with medically underserved populations2 7,i7 at least one such member shall be a ,state-certified substance use disorder peer support specialist2 7,j7 at least one such member shall be a drug court judge or a judge with experience in adjudicating cases related to substance use disorder2 7,k7 at least one such member shall be a law enforcement officer or correctional officer with extensive experience in interacting with adults with a substance use disorder2 and 7,l7 at least one such member shall be an individual with experience providing services for homeless individuals and working with adults with a substance use disorder4 7c7 ,terms 7#a7 ,in general ,a member of the ,committee appointed under subsection 7b77#b7 shall be appointed for a term of #c years and may be reappointed for one or more #c-year terms4 7#b7 ,vacancies ,a vacancy on the ,committee shall be filled in the same manner in which the original appointment was made4 ,any individual appointed to fill a vacancy for an unexpired term shall be appointed for the remainder of such term and may serve after the expiration of such term until a successor has been appointed4 7d7 ,meetings ,the ,committee shall meet not fewer than two times each year4 7e7 ,duties ,the ,committee shall-- 7#a7 monitor opioid use disorder and other substance use disorder research1 services1 and support and prevention activities across all relevant ,federal agencies1 including coordination of ,federal activities with respect to opioid use disorder and other substance use disorders2 7#b7 identify and provide to the ,secretary recommendations for improving ,federal grants and programs for the prevention and treatment of1 and recovery from1 opioid use disorder and other substance use disorders2 7#c7 review substance use disorder prevention and treatment strategies in different regions and populations in the ,united ,states and evaluate the extent to which ,federal substance use disorder prevention and treatment strategies are aligned with ,state and local substance use disorder prevention and treatment strategies2 7#d7 make recommendations to the ,secretary regarding any appropriate changes with respect to the activities and strategies described in paragraphs 7#a7 through 7#c72 7#e7 make recommendations to the ,secretary regarding public participation in decisions relating to opioid use disorder and other substance use disorders and the process by which public feedback can be better integrated into such decisions2 and 7#f7 make recommendations to ensure that opioid use disorder and other substance use disorder research1 services1 and support and prevention activities of the ,department of ,health and ,human ,services and other ,federal agencies are not unnecessarily duplicative4 7f7 ,annual report 7#a7 ,in general ,not later than #a year after the date of the enactment of this ,act1 and annually thereafter for the life of the ,committee1 the ,committee shall publish on the public information dashboard established under section #b7;a7 a report summarizing the activities carried out by the ,committee pursuant to subsection 7e71 including any findings resulting from such activities4 7#b7 ,recommendation for ,committee extension ,after the publication of the second report of the ,committee under paragraph 7#a71 the ,secretary shall submit to ,congress a recommendation on whether or not the operations of the ,committee should continue after the termination date described in subsection 7i74 7g7 ,working groups ,the ,committee may establish working groups for purposes of carrying out the duties described in subsection 7e74 ,any such working group shall be composed of members of the ,committee 7or the designees of such members7 and may hold such meetings as are necessary to enable the working group to carry out the duties delegated to the working group4 7h7 ,federal ,advisory ,committee ,act ,the ,federal ,advisory ,committee ,act 7#e ,u4,s4,c4 ,app47 shall apply to the ,committee only to the extent that the provisions of such ,act do not conflict with the requirements of this section4 7i7 ,sunset ,the ,committee shall terminate on the date that is #f years after the date on which the ,committee is established under subsection 7a74 ,passed the ,house of ,representatives ,june #ab1 #bjah4;,clerk4